WHO ICTRP trial

Study on the vascular effects of ACE-I + CA-antagonist (Enalapril +…

EUCTR2008-005006-39-IT · EU Clinical Trials Register · Authorised

Key facts

Trial ID EUCTR2008-005006-39-IT
Public title Study on the vascular effects of ACE-I + CA-antagonist (Enalapril + Lercanidipine) versus ACE-I + diuretic (Enalapril + hydrochlorothiazidE) combinations in hypertensive patients with metabolic syndrome not sufficiently controlled by ACE-I monotherapy - ND
Scientific title Study on the vascular effects of ACE-I + CA-antagonist (Enalapril + Lercanidipine) versus ACE-I + diuretic (Enalapril + hydrochlorothiazidE) combinations in hypertensive patients with metabolic syndrome not sufficiently controlled by ACE-I monotherapy - ND
Primary sponsor AZIENDA OSPEDALIERA PISANA
Registry EU Clinical Trials Register
Recruitment status Authorised
Study type Interventional clinical trial of medicinal product
Countries Italy
Conditions hypertensive patients of either sex aged 40-69 years MedDRA version: 9.1 Level: HLGT Classification code 10057166 MedDRA version: 9.1 Level: SOC Classification code 10047065 MedDRA version: 9.1 Level: SOC Classification code 10047065 MedDRA…
Interventions Pharmaceutical Form: Tablet INN or Proposed INN: Enalapril Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 20- Pharmaceutical Form: Tablet INN or Proposed INN: Lercanidipine Concentration unit: mg…
Registration date Feb 19, 2009
Secondary IDs selene 2008
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations